|
J Biol Chem, Vol. 274, Issue 53, 37932-37940, December 31, 1999
A Novel Gonadotropin-regulated Testicular RNA Helicase
A NEW MEMBER OF THE DEAD-BOX FAMILY*
Pei-Zhong
Tang,
Chon-Hwa
Tsai-Morris, and
Maria L.
Dufau
From the Section of Molecular Endocrinology, Endocrinology and
Reproduction Research Branch, NICHHD, National Institutes of Health,
Bethesda, Maryland 20892
 |
ABSTRACT |
A gonadotropin-regulated testicular RNA helicase
(GRTH) was identified and characterized. GRTH cloned from rat Leydig
cell, mouse testis, and human testis cDNA libraries is a novel
member of the DEAD-box protein family. GRTH is transcriptionally
up-regulated by chorionic gonadotropin via cyclic AMP-induced androgen
formation in the Leydig cell. It has ATPase and RNA helicase activities and increases translation in vitro. This helicase is highly
expressed in rat, mouse, and human testes and weakly expressed in the
pituitary and hypothalamus. GRTH is produced in both somatic (Leydig
cells) and germinal (meiotic spermatocytes and round haploid
spermatids) cells and is developmentally regulated. GRTH predominantly
localized in the cytoplasm may function as a translational activator.
This novel helicase could be relevant to the control of steroidogenesis and the paracrine regulation of androgen-dependent
spermatogenesis in the testis.
 |
INTRODUCTION |
The closely related gonadotropins, luteinizing hormone
(LH)1 and human chorionic
gonadotropin (hCG), exert their functions through specific G
protein-coupled receptors in gonadal cells. Physiological
concentrations of gonadotropins maintain the steroidogenic function of
the Leydig cells of the testis (see Ref. 1 for review). However, high
concentrations of gonadotropins cause desensitization of steroidogenic
enzymes of the androgen pathway, with consequent reduction of
testosterone formation (2-5). The attenuation of steroidogenesis
results from receptor activation by the gonadotropic hormone but is
independent of the subsequent phase of receptor down-regulation. The
control of the enzymes involved in this regulation including
3 -hydroxysteroid dehydrogenase types I and II (3), 17 -hydroxylase/17, 20 lyase (5), and 17 -hydroxysteroid
dehydrogenase type III (4) operates at the transcriptional level.
Because this process affects several enzymes, the direct or indirect
involvement of a master switch has been proposed (3). Likely candidates for this regulation include the active steroid metabolites that are
produced during gonadotropic stimulation, i.e. androgen (3) and estrogen (6-8).
To identify potentially relevant proteins that participate in
gonadotropin up- or down-regulation of steroidogenic enzymes at the
transcriptional or post-transcriptional level, we utilized differential
display analysis of RNA from testicular Leydig cells subjected to a
single exposure of gonadotropin in vivo. We report the
demonstration of a novel gonadotropin-regulated testicular RNA helicase
(GRTH) that belongs to the family of DEAD-box proteins and is
predominantly expressed in Leydig and germinal meiotic cells of the
testis. This protein was found to be markedly up-regulated in the
Leydig cell by hCG doses that cause steroidogenic desensitization. It
is likely that GRTH serves in general to maintain receptors, enzymes,
and factors that support testicular functions and spermatogenesis.
 |
EXPERIMENTAL PROCEDURES |
Animal Treatment and Cell Preparation--
Gonadotropin-induced
LH receptor and steroidogenic enzymes down-regulation of Leydig cells
was produced as described previously (2) by administration of a single
2.5-µg subcutaneous injection of hCG (Pregnyl, Organon) to adult male
rats (200-250 g) (Charles River Laboratories Inc., Wilmington, MA).
Animals were sacrificed 24 h after hCG treatment, and testes were
removed. Leydig cells were prepared by collagenase dispersion and
purified by centrifugal elutriation as described previously (9). The
cells were frozen at 70 °C until the further extraction of RNA.
Following collagenase dispersion to obtain Leydig cells, the
seminiferous tubules were further treated with collagenase (0.05%)
until no interstitial cells remained adhered to the tubules as assessed
under inverted microscope. Tubules were minced into 1-2-mm segments,
resuspended in Medium 199, 0.1% BSA, and shaken (120 rpm/min) for 20 min at 37 °C. The fragments were allowed to settled for 5 min, and
germ cells were collected from supernatant by centrifugation.
In Vitro Study of the Hormonal Regulation of GRTH Leydig Cells in
Primary Culture--
Leydig cells were plated (1 × 106 cells/ml) for 1 h and incubated with hCG or
8-bromo-cAMP or buffer (control) for 20 h. In studies conducted to
examine the effects of endogenous or exogenous steroids, cells were
preincubated with or without inhibitors of steroid biosynthesis
(aminoglutethimide, 100 µg/ml; cyanoketone, 1 µM, and
spironolactone, 10 µM (Sigma) for 20 min at 34 °C and kept throughout the culture. The cells were then incubated with hormones for 20 h. These compounds were previously found to
inhibit effectively the enzymes of the steroidogenic pathway in the
Leydig cells and consequently inhibited testosterone production
(9-12). The enzymes blocked by the inhibitors included cholesterol
side chain cleavage and aromatase (aminoglutethimide),
3 -hydroxysteroid oxidoreductase -5 isomerase (cyanoketone), and
17 -hydroxylase/17-20 desmolase (spironolactone). Total RNA was
isolated from Leydig cells using TRIzol RNA reagent (Life Technologies,
Inc.). Levels of GRTH mRNA were analyzed by Northern blot.
Differential Display Analysis--
Three sets of total RNA
samples (300 ng for each) independently prepared from Leydig cells of
rats treated with and without hCG were analyzed by differential display
essentially as described previously (13). Briefly, samples were
reversed-transcribed using six downstream primers followed by PCR with
the same downstream primer and 12 different upstream primers (random
10-mers). PCR products with incorporated [33P]dATP (2000 Ci/mmol, NEN Life Science Products) were separated in non-denatured 6%
sequencing gels. Gels were dried and evaluated by autoradiography.
Regions containing differential bands on the gel were excised and
eluted by electrophoresis. The products were reamplified and resolved
by single strand conformation polymorphism gels to confirm that a
single differential fragment was contained in each excised band. The
differential bands were eluted, reamplified by PCR, separated on a
1.5% agarose gel, and eluted by electrophoresis. The differential
fragments were cloned and sequenced. The nucleotide sequences were
compared with sequences in the GenBankTM/EMBL data bases
using FASTA program. The individual bands were verified by RNA
protection analysis.
RNase Protection Assay--
RNase protection assays were
performed by established methodology (14). The GRTH cRNA probe was
generated by PCR followed by subcloning and in vitro
transcription. Primers were used to amplify a fragment complementary to
the coding region (256-611 nt position), see Fig. 1. Also, primers
located at exons 4 and 5 of the rat -actin gene were employed to
amplify the -actin fragment (270 bp) used as control. The constructs
were linearized and used as template for the in vitro
transcription with RNA polymerase T7 (Life Technologies, Inc.) and
labeled with [32P]UTP (800 Ci/mmol, ICN Biomed). 10 µg
of total RNA samples were applied for hybridization. Ribonuclease T1
and ribonuclease A (Life Technologies, Inc.) were used for the
digestion of unhybridized RNA and cRNA probe. The protected fragments
were resolved on 6% sequencing gels and quantified by PhosphorImager analysis.
Isolation and Cloning of Rat Leydig Cell and Mouse and Human
Testis GRTH cDNA--
The PCR fragment derived from differential
display analysis was labeled with [32P]dCTP and used as
probe for screening of a rat Leydig cell cDNA library in ZAP
ExpressTM vector (Stratagene, La Jolla, CA). Superscript
mouse and human testis cDNA libraries (Life Technologies, Inc.)
were screened with [32P]dCTP-labeled PCR fragments
256-601 and 475-1065 (nt positions) of rat GRTH. Positive clones for
each screened library were isolated and sequenced.
Chromosomal Localization--
Chromosomal mapping (rat, mouse,
and human) was performed using fluorescence in situ
hybridization (FISH) signal mapping and 4',6-diamidino-2-phenylindole
stain to assign chromosome number (see DNA Biotech Inc. Windsor,
Canada). GRTH cDNA probe of 1.6 kb (rat, mouse, and human) was
biotinylated with dATP using the Life Technologies, Inc., BioNick
labeling kit (15 °C for 1 h) (15) and used for hybridization
(16 h) of denatured chromosomal slides. Under the conditions used, FISH
detection efficiencies were 68% (human), 61% (mouse), and 71% (rat)
for this probe among 100 mitotic figures checked.
Northern Blot, mRNA Stability, and Nuclear Run-off
Assay--
mRNA was extracted from rat Leydig cells and from
various male and female rat tissues using Fast-Track mRNA isolation
kits (Invitrogen, Carlsbad, CA). The mRNA samples (5 µg) were
resolved on 1% agarose gels, transferred onto a GeneScreen membrane
(Biotechnology System, NEN Life Science Products), and hybridized with
32P-labeled rat GRTH cDNA probe (1.6 kb) at 50 °C
overnight. To investigate the stability of the GRTH mRNA, cells
were incubated with 10 µg/ml actinomycin D for 0-10 h in medium 199, 0.1% BSA. 10-µg mRNA samples were resolved as described above.
Hybridization was quantified by PhosphorImager analysis. Nuclear
run-off assays were performed as described previously (3, 16).
Transient Cotransfection Analyses of GRTH cDNA with Different
Promoter-Luciferase Constructs--
GRTH cDNA (1 µg) inserted in
plasmid pBK (pBK-GRTH) or plasmid only (pBK) as a control was
transiently cotransfected into mLTC cells with different gene core
promoters constructed in pGL plasmid (2 µg), anchored with luciferase
cDNA as a reporter gene using Cytofectin GS-3815 (Glen Research,
Sterling, VA). Luciferase activity and mRNA were quantitated.
In Situ Hybridization Analysis of GRTH mRNA in Rat
Testis--
In situ hybridization was carried out following
standard protocols (17). Briefly, testes from prepubertal, pubertal,
and adult animals were fixed in 4% paraformaldehyde for 16 h at
22 °C. Slides were hybridized to 35S-labeled GRTH cRNA
probes (sense and antisense) for 16 h at 45 °C. The probes were
synthesized by in vitro transcription using a Maxiscript kit
(Ambion Inc, TX) and 35S-UTP (1250 Ci/mmol). Following the
hybridization procedure, slides were coated with K5 emulsion (Ilford,
UK) and exposed for at least 4 days. Slides counterstained with
hematoxylin-eosin were photographed using bright- and dark-field optics
and polarized epi-illumination. For preparation of purified Leydig
cells a plasma clot of the cells was prepared and processed.
Subcellular Localization of Rat GRTH in mLTC Cells Using Living
Colors GFP System and Confocal Microscopy--
The full length of GRTH
cDNA coding region was subcloned into the pEGFP-N3 vector
(GRTH-EGFP). The cDNAs of GRTH-EGFP (2 µg/ml) or pEGFP vector
only (2 µg/ml) were transfected into mLTC cells using Cytofectin
GS-3815. After 24 h of incubation the cells were examined in an
inverted microscope under a 40× oil-immersion objective (Nikon, Inc.,
Melville, NY) and a Bio-Rad laser confocal microscope system
(MRC-1024). Also the mLTC cells transfected with and without GRTH-EGFP
or EGFP were harvested for Western blot analyses using GFP monoclonal
antibody (CLONTECH).
In Vitro Transcription/Translation of GRTH cDNA--
The rat
1.6-kb GRTH cDNA (1 µg) cloned in the pBK-CMV vector containing a
T3 promoter (pBK-GRTH) was in vitro transcribed and
translated into protein using the T3-coupled Reticulocyte Lysate System
(Promega, Madison, WI) following the manufacturer's protocol. The
vector without insert (pBK) was used as negative control.
[35S]methionine (Amersham Pharmacia Biotech) was added to
the translation reaction, and the labeled translated protein samples
were then resolved on 10% SDS-polyacrylamide gels.
In Vitro Translation Assays--
Luciferase RNA poly(A) template
was generated by the in vitro transcription of the
full-length luciferase cDNA cloned in the pSP64 poly(A) vector
(Promega). In vitro translation assays were carried out in a
50-µl reaction with additions of purified recombinant GRTH-GST fusion
protein or GST (250 and 500 ng), 20 µCi of
[35S]methionine (1000 Ci/mmol, 10 mCi/ml, Amersham
Pharmacia Biotech), 20 µM amino acid mixture lacking
methionine, 40 units of ribonuclease inhibitor, 1 µg of luciferase
RNA, and 25 µl of reticulocyte lysate treated with micrococcal
nuclease containing 2.5-µg mixture of tRNAs, 1 µg of hemin, 4 mM potassium acetate, and ATP-regenerating system
phosphocreatinine/phosphocreatinine kinase. Samples were incubated for
90 min at 30 °C. The 61-kDa radiolabeled luciferase translated
protein was resolved on 10% SDS-polyacrylamide gel. Autoradiograms
were quantitated by Imaging Densitometer model GS-700 (Bio-Rad) and
expressed as percent of GST control.
Expression and Purification of Rat GRTH from Bacteria--
The
GRTH cDNA was subcloned into pGEX-2T glutathione
S-transferase (GST) gene vector (GRTH-GST). The construct
was verified by sequence and transformed into Escherichia
coli BL21. The MicroSpinTM GST Purification Module
System (Amersham Pharmacia Biotech) was used for the purification of
GRTH-GST fusion protein. The purified protein recovered from the
columns was aliquoted and analyzed by SDS-PAGE and Western blot analyses.
Preparation of Helicase Substrates--
The long strand of RNA
(5'-GGCCGAAUUGGGUACACUUACCUGGUACCCCACCCGGGUGGAAAAUCGAUGGGCCCGCGGCCGCUCUAGAAGUACUCUCGAGAAGCUUUUUGAAUU-3') was synthesized by in vitro transcription and purified
by gel electrophoresis. The short strand of RNA (5'-GGCCCAUCGAUUUU-3') with 5'-hydroxyl terminus complementary to the middle region of the
long strand of RNA was synthesized by Cruachem Inc. (Dulles, VA). All
the DNA oligomers were synthesized by DNA synthesizer. The sequence of
the long DNA oligomer corresponds to the long strand of RNA. The three
short DNA oligomers (5'-TTCTAGAGCGGCCGCGGGCC-3'; 5'-TAAGTGTACCCAATTCGCCC-3'; and 5'-TTCAAAAAGCTTCTCGAGAG-3')
correspond to the mid-region, 5'-end, and 3'-end of the long RNA
strand, respectively. The short strands of RNA and DNA were labeled by 32P using T4 polymerase kinase (Life Technologies, Inc.)
and [ -32P]ATP. Labeled short strands (15 pmol) were
annealed to long strands (10 pmol) by gradually decreasing the
temperature from 90 to 4 °C within 3 h in the buffer of 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 2 mM MgCl2, 1 mM EDTA. The annealed
substrates were resolved on 4% agarose gels, eluted by
electrophoresis, and precipitated by ethyl alcohol. The purified
substrates were dissolved in the helicase assay buffer.
Helicase and ATPase Activity Assays--
The helicase assay was
carried out in 15 µl of buffer (20 mM HEPES-KOH (pH 7.5),
50 mM KCl, 3 mM MgCl2) containing
0.1 mg/ml BSA, 1 unit/µl RNase inhibitor (Promega), 0.4 mM dithiothreitol, 1 mM ATP, 0.2 pmol double
strand substrates, and different amounts (0.1 to 1.0 µg) of purified
GRTH-GST or GST (control) proteins. The mixture was incubated for 30 min at 37 °C. Double-stranded substrates boiled for 3 min were used
as positive controls. Aliquots (10 µl) of each reaction were
separated by 8% native polyacrylamide gels and recorded by
radioautography. The ATP hydrolysis activity was analyzed as described
previously (18). 1.5 µg of purified GRTP-GST or GST (control)
proteins and 0.3 A260 units of different RNAs
(mRNA and total RNA from rat Leydig cell, tRNA from yeast, poly(A)
and poly(U) from Life Technologies, Inc.) were used for each reaction.
All experiments were performed at least three times in triplicate.
Statistical significance was evaluated by analysis of variance.
 |
RESULTS |
Identification, Isolation, and Cloning of a Novel
Gonadotropin-regulated Testicular Gene GRTH--
To identify genes
that are regulated by gonadotropin, we compared differential display
patterns of RNA obtained from Leydig cells of rats treated with a
single desensitizing dose of hCG (2.5 µg) or vehicle alone 24 h
prior to sacrifice. Differential display PCR using 6 downstream and 12 upstream primers (see "Experimental Procedures") revealed 30 differential candidate bands that were observed in the three different
RNA samples, of which 6 were up-regulated and 24 were down-regulated.
After single-strand conformation polymorphism analysis, sequencing of
the fragments, and RNA protection verification, one up-regulated
fragment and six down-regulated fragments were obtained. PCR
amplifications using primers 5'-dT11GA-3' and 5'-GATCATGGC-3' revealed
a 84-bp fragment which appeared to be up-regulated by the hormone is
shown in Fig. 1A, left. This
3' fragment displayed no similarity to any gene on the Data Bank.
Subsequently, RNase protection assays using the 84-bp fragment and a
355-bp GRTH cDNA derived from the coding region (see below)
confirmed that this gene was up-regulated by hCG (Fig. 1A,
middle). The protected fragment of -actin mRNA (290 bp)
used as an internal control in this study showed no change.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 1.
A, up-regulation of GRTH by hCG
identified by mRNA differential display analysis (left)
and confirmed by RNase protection assay (middle) in rat
Leydig cells and in vitro translation and mammalian
expression (right). Differential display analysis of three
sets of total RNA samples from Leydig cells of rats treated 24 h
prior with a single dose of hCG (2.5 µg) (+) or vehicle
alone ( ). One PCR fragment (84 bp), indicated by
arrows in the cDNA sequence below, was up-regulated by
hCG treatment (left). Autoradiography of RNase protected
fragments. Total RNA samples (10 µg) were hybridized to
32P-labeled cRNA GRTH probes: the 84-bp probe (differential
display PCR product) and a 355-bp probe (+256 to +611 nt) from the GRTH
coding region (shown by arrows with asterisks)
simultaneously with a -actin fragment (290 bp) probe as internal
control (middle). In vitro transcribed/translated
GRTH and GRTH cDNA (GRTH-V5) expressed in mLTC cells was
detected by V5 antibody (right). B, rat, mouse,
and human GRTH cDNA nucleotide and deduced amino acid sequences of
the rat encoded protein. The complete nucleotide sequence of the rat
GRTH (1629 bp) is derived from screening a rat Leydig cell cDNA
library. An open reading frame of 369 amino acids is shown
below the nucleotide sequence. Differences of the human
(h) and mouse (m) GRTH from the rat
(r) sequence are indicated in lowercase letters
above the rat sequence. The deduced amino acid rat, mouse, and human
sequences of GRTH contain all conserved domains of DEAD-box family of
RNA helicases (underlined).
|
|
To characterize the cDNA sequence of this hCG-regulated mRNA,
the 32P-labeled 84-bp PCR fragment was used as a probe to
screen a rat Leydig cell cDNA library. The full-length sequence
(1629 bp) contained an open reading frame encoding 369 amino acids
(Fig. 1B) (GenBankTM accession number AF142629).
The in vitro transcribed/translated rat GRTH cDNA
yielded a protein of 43 kDa (Fig. 1A, right), in agreement
with the expected size from the deduced amino acid sequence of 369 amino acids (Fig. 1B). Furthermore, mLTC cells transfected by rat GRTH cDNA with a V5 tag expressed a protein of molecular size comparable to the in vitro translated GRTH protein
(Fig. 1A, right). Also, the mouse and human GRTH cDNA
sequences were isolated from mouse and human testis cDNA libraries.
The nucleotide and deduced amino acid sequences of the mouse
(GenBankTM accession number AF142630) displayed 96 and 99%
similarity to the rat sequence, respectively, and those of the human
sequences (GenBankTM accession number AF155140) were 86 and
95% similar to the rat.
A data base search using the FASTA program of GCG revealed similarity
of the rat GRTH sequence to those members of the DEAD-box family of RNA
helicase and contained the seven highly conserved signature regions of
the family (Fig. 1B, underlined) including the
(A/S)XXGXGKT and DEAD domains involved in ATP
binding and/or ATP hydrolysis and SAT and HRIGRXXR domains
involved in RNA binding and unwinding (19). A phylogram produced by the
PILEUP program of the GCG package based on 116 members of the DEAD-box
family indicated that GRTH is genetically close to mouse DEAD5, a
protein of unknown function (70%, amino acid identity) (20) and yeast Dbp5p, required for poly(A) RNA export (49%) (21). It is less related
to initiator factors (eIF4As) of the translation complex in several
species (41-42%) (22), the human oncogene RCK homolog DDX6
(36%) (23), Drosophila Me31B required for oogenesis (37%) (24), and yeast Ste13 required during mating (37%) (25). GRTH is more
distantly related to mouse PL10, a protein found in cells of the
germinal epithelium (35%) (26), and human p68, a protein related to
cell growth and division (32%) (27).
Chromosomal Localization of GRTH--
Chromosomal mapping using
human, mouse, and rat lymphocytes revealed that this gene resides in
chromosomes 11q24 (human), 8q21 (rat), and 9A3-A5 (mouse) (Fig.
2). A search of mouse to human homology
region indicated that genes mapped in the region of mouse 9A3-A5 mostly
corresponded to the region of human 11q22-24, including the potassium
inwardly rectifying channel subfamily J members 5 (GIRK4), Friend
leukemia virus integration 1 (FLIL) genes, and DDX6 genes
(23).

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 2.
Chromosome mapping of rat, mouse, and human
GRTH gene. On the left are shown the FISH signals for
each species. On the right are provided the corresponding
mitotic figures stained with 4',6-diamidino-2-phenylindole for
chromosomal identification and region assignment. In the diagrams each
dot represents double FISH signals detected (detailed
positions were determined based on data from 10 individual
photographs).
|
|
Localization of GRTH by in Situ Hybridization--
Cellular
localization of GRTH mRNA within the rat testicular compartments
revealed that GRTH transcripts were present in both interstitial and
germ cells of the adult testis (Fig. 3).
Some of the interstitial cells showed strong signals and others were negative. Variations were observed among the individual interstitial spaces (Fig. 3, C and D). In highly purified
Leydig cell preparations (95% purity) isolated from the interstitial
compartment of the adult rat testis, 60% of the cells (from 500 cells
counted) were positive (Fig. 3A). Since these animals had
not received exogenous hormone treatment, these observations likely
reflect the stimulation/maintenance of expression by endogenous
gonadotropin/androgen. Prominent and dense labeling within the
seminiferous tubules of adult rats was highest in cells in meiotic
phase, predominantly in pachytene spermatocytes (Fig. 3I).
GRTH mRNA was also present in round spermatids of the adult rat
testis (Fig. 3K). Cells within the basal compartment, including spermatogonia and preleptotene spermatocytes, were clearly negative as were the Sertoli cells (Fig. 3J). In the
pubertal testis, only cells in meiotic phase, mainly pachytene
spermatocytes, were positive. Again basally located cells, including
Sertoli cells, were negative (Fig. 3H). Developmental
studies demonstrated that GRTH was not present in the testis of
immature animals (8 and 12 days old, data not shown), but positive
signals were present in tubules and Leydig cells of pubertal animals
(23 and 26 days) and in the adult testis. Under low magnification (× 5), it was evident that at the pubertal stage some tubules were frankly
positive, and others showed low positivity (indicated by the presence
of a bright or pale ring, respectively, within the seminiferous tubule) (Fig. 3F). In contrast, in the adult testis all tubules were
positive, with some gradations in grain density (not shown). These
studies, and those presented in Fig.
4A, demonstrate that the
expression of GRTH in the testis is developmentally regulated.

View larger version (71K):
[in this window]
[in a new window]
|
Fig. 3.
Cellular localization of GRTH in the rat
testis by in situ hybridization. Detection of rat
GRTH mRNA in isolated Leydig cells and tissue section by in
situ hybridization, photographed by dark field (A, B,
F, and G), bright (C and H), and
epi-illumination/bright field microscopy (D, E, I, J, and
K). A, 60% of purified rat Leydig cells are
positive. B, Leydig cells incubated with sense probe are
negative. C, some interstitial cells in adult testis that
resemble Leydig cells are positive (black arrow), and others
are negative (white arrow). D, several
interstitial cells in the adult testis that resemble Leydig cells close
to the blood vessel are positive. E, negative sense control
for D. F, positive signal in germ cells within
the seminiferous tubules of day 23 pubertal testis. G,
negative, sense control for F. H, positive signal
is noted only in germ cells at meiotic phase in pubertal testis,
including pachytene spermatocytes. Basal cells including spermatogonia
and Sertoli cells (arrowhead) are negative. I, an
overexposed view to demonstrate mRNA expression in meiotic germ
cells of adult testis but negative in spermatogonia and preleptotene
spermatocytes at the periphery. J, positive signal is noted
only in meiotic germ cells of adult testis. Arrowhead points
to negative Sertoli cells. K, positive signals in both round
spermatids (top tubule) and pachytene spermatocytes
(bottom tubule) in adult testis. Bars = 25 µm.
|
|

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 4.
A, Northern blot analysis of GRTH
mRNA. mRNA samples isolated from several adult tissues of male
rats and from ovaries of cycling (ovary) and pregnant
(preg.) female rats; Leydig cells
(L.C.) and germ cells (GC) obtained from adult
rats treated with 2.5 µg of hCG (+) or control
( ); adult rat, mouse, and human testes and tumor rat
(R2C) and mouse (mLTC) Leydig cell
lines; testes of different ages as follows: mouse,
pre-pubertal (2 weeks), pubertal (4 weeks), and adult (8 weeks); rat,
pre-pubertal (1 and 2 weeks), pubertal (3 and 4 weeks), and adult (6 and 8 weeks). Samples were hybridized with a rat GRTH cDNA probe
(1.6 kb) and rehybridized with cDNA -actin probe. B,
time course study of GRTH mRNA regulated by hCG. Leydig cells from
male rats injected with 2.5 µg of hCG after 1-12 h treatment (short
term) and 1-9 days (long term). RNase protection assays were performed
for the short term study, and Northern blot analyses were performed for
long term study. Data normalized by -actin are presented as percent
mean ± S.E. relative to saline control. C, stability
of GRTH mRNA (left) and nuclear run-off assay
(right). Gonadotropin-desensitized Leydig cells were
obtained 12 h after treatment from rats with a single dose of hCG
(2.5 µg). Cells were incubated with 10 µg/ml actinomycin D for
0-10 h. The mRNA samples (10 µg) were analyzed by Northern blot
(left). Nuclei prepared from control and hCG-desensitized
Leydig cells in the presence of [32P]UTP were analyzed by
nuclear run-off assay (right). The newly transcribed RNAs
were hybridized to a nitrocellulose membrane on which cDNAs of GRTH
(20 µg), -actin (20 µg), and vector (20 µg) have been
immobilized. Results were recorded by autoradiography for visual
display (upper) and quantified by PhosphorImager
(lower). Data are percent of means ± S.E. relative to
control.
|
|
Tissue and Cell Distribution of GRTH Transcripts--
The tissue
distribution of the GRTH transcript studied by Northern blot analysis
detected a single transcript of 1.6 kb. In Fig. 4A, it is
shown that GRTH is predominantly expressed in the testis and less
abundantly in the hypothalamus, pituitary, and brain but was not
expressed in ovary or other tissues examined (Fig. 4A, left
panel). GRTH mRNA was detected in Leydig cells (L.C.), and its abundance was comparable to that observed in
germ cells (GC). In germinal cells, mRNA levels were
very similar in both hCG-treated and untreated groups in contrast to
the mRNA of Leydig cells from hCG-treated adult animals (+) which
was significantly increased when compared with control. Northern blot
analysis also detected a single transcript in adult normal human testis
(Cooperative Human Tissue Network, Philadelphia, PA) and mouse testis
(Fig. 4A, middle). However, GRTH mRNA was not expressed
in mouse (mLTC) and rat (R2C) tumor Leydig cell
lines, whereas -actin mRNA was present at similar levels in the
samples. GRTH was abundantly expressed in the adult testis in both
Leydig cells (interstitium) and germ cells (tubules). Developmental
studies demonstrated that testicular GRTH mRNA levels were very low
in 1-2-week immature animals (Fig. 4A, right). However, the
mRNA levels were markedly increased (40-fold) during early puberty
(weeks 3 and 4). After puberty, when the spermatogenic process is
completely established, the GRTH mRNA levels in adult mouse and rat
testes were not significantly increased over those observed in early
pubertal or pubertal animals. This stage-specific expression of
mRNA indicated that GRTH may play a role in spermatogenesis.
hCG-induced Up-regulation of GRTH mRNA in Rat Leydig
Cell--
To gain insights into the characteristics of the regulatory
mechanism(s) of hCG-mediated GRTH mRNA up-regulation and its
correlation with the down-regulation of steroidogenic enzymes in the
Leydig cell described in our previous studies, temporal studies were conducted following the administration of a desensitizing dose of hCG
(2.5 µg). No significant changes in GRTH mRNA levels were observed at 1 and 4 h, whereas these were significantly increased at 12, 19, and 24 h (p < 0.01, p < 0.001, p < 0.001) and returned gradually to
near-control and control levels at days 4 and 9 after hCG treatment,
respectively (Fig. 4B).
Up-regulation of GRTH mRNA by hCG at Transcriptional
Level--
To explore whether increases in GRTH mRNA induced by
hCG were related to changes in mRNA stability, we assessed GRTH
mRNA degradation rates. The mRNA levels at different times
after treatment with actinomycin D were generally higher in the samples
from hCG-treated animals than in controls (Fig. 4C). Only
20% of GRTH mRNA was degraded after 10 h of actinomycin D
treatment in samples from both treated and non-treated groups which
indicated that the half-life of GRTH mRNA in Leydig cells was very
long. The degradation rates between the two groups were very similar.
This indicated that up-regulation of GRTH mRNA in the Leydig cells
was not due to stabilization of the mRNA by hCG but rather to a
change in transcriptional activity. Nuclear run-off assays demonstrated
that newly synthesized GRTH 32P-labeled Leydig cell
mRNA from hCG-treated animals increased when compared with
non-treated controls, whereas -actin (control) remained unchanged
(Fig. 4C).
In Vitro Study of the Hormonal Regulation of GRTH in the Primary
Cultures of Leydig Cells--
To elucidate further the mechanism of
hCG-induced GRTH mRNA increase in Leydig cells, in vitro
studies were performed in primary Leydig cell cultures. Both hCG and
cAMP cause increases in GRTH mRNA levels by 35 and 41%,
respectively (p < 0.01) (Fig.
5A). The increases of GRTH
mRNA induced by hCG (Fig. 5B) or cAMP (not shown) were
prevented by inhibitors of steroidogenic enzymes that abolished the
stimulation of the formation of active androgens, estrogen, and their
precursors (10). Dihydrotestosterone increased GRTH mRNA level by
40% in primary cultures of Leydig cells, in which the production of
endogenous steroids had been blocked by the addition of inhibitors
(Fig. 5B). In contrast, estradiol had no effect on GRTH
expression. Thus, the fact that hCG was unable to stimulate GRTH
expression when endogenous production of androgen action was blocked by
the inhibitors of steroidogenic enzymes, coupled to the finding that
dihydrotestosterone was able to elicit similar increases as hCG in
these cells, strongly indicated that hCG-induced GRTH expression was
mediated through the action of androgens in Leydig cells. GRTH levels
in controls were due to the presence of endogenous androgens in the
cells, and these were not changed in cultures where steroidogenesis was
inhibited. This is expected since the incubation time of the primary
culture was relatively short and the half-life of GRTH is long to
reveal the impact of the reduced androgen levels.

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 5.
Hormonal regulation of GRTH in primary Leydig
cells cultures in vitro. A, Northern
blot analysis of GRTH mRNA from Leydig cells treated with hCG (10 ng/ml) or 8-bromo-cAMP (1 mM) or phosphate-buffered saline
(control) for 20 h. B, Leydig cells preincubated with
or without the inhibitors of steroidogenic enzymes and androgen
production for 20 min, followed by 20 h incubation with 50 nM estradiol (E2) or 100 nM
dihydrotestosterone (DHT) or hCG. Results were quantified by
PhosphorImager (counts were normalized by -actin). Data are
presented as percent of means ± S.E. relative to control in
A or the inhibitor (Inh.) alone in
B.
|
|
Exploring the Function of GRTH--
To examine whether GRTH was
involved in the regulation of Leydig cell steroidogenic enzymes and
receptors, and to gain further insights into the cellular function of
GRTH, we evaluated the changes induced by cotransfected GRTH (GRTH-pBK)
on luciferase activity generated from constructs containing the
luciferase reporter gene driven by promoters of relevant Leydig cell
genes in mLTC cells (Fig. 6A,
left). An increase of 50-80% in luciferase activity over
controls (pBK) was observed with the four constructs bearing relevant
promoters. This finding demonstrated that the hCG-induced down-regulation of the expression of these genes observed in our previous studies (3-5) was not related to the up-regulation of GRTH.
The similar increase in activity with the four gene promoters indicated
that the GRTH action was related to a general mechanism not concerned
with the regulation of transcription. This was supported by the
observation that a construct bearing a promoter of a gene not expressed
in the Leydig cell (SV-40) was also stimulated by GRTH. In contrast,
simultaneous quantitation of luciferase mRNA by RNase protection
assay in mLTC cells cotransfected with GRTH cDNA (pBK-GRTH)
revealed no changes when compared with cells cotransfected with pBK
empty vector, lacking GRTH (Fig. 6A, right). This finding supports the notion that the increase of luciferase activity induced by
GRTH was not due to transcriptional stimulation of the gene promoter
but likely to changes at the translational level. In vitro
translation studies demonstrated that recombinant GRTH-GST (250 and 500 ng) increased translation of luciferase RNA template over GST control
by 100 and 200%, respectively (Fig. 6B). This further
indicated the potential role of GRTH in translation.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
A, left, cotransfection of
pBK-GRTH or plasmid pBK with different gene core promoters/luciferase
in mLTC cells. Luciferase activity was evaluated as indicative of
luciferase protein expression. hLHR174 and
r-LHR174, human and rat luteinizing hormone receptor
promoters (36, 37); PRLR-P1, rat prolactin receptor
promoter-1 (38); P450-17 , rat 17 -hydroxylase/17,20
lyase promoter (39); SV40, eukaryotic simian virus-40
promoter. Right, quantitation of luciferase mRNA by RNA
protection assay. A portion of mLTC cells cotransfected with pBK-GRTH
or pBK with r-LHR174/luciferase was used for luciferase mRNA
quantitation. Data are presented as percent of means ± S.E.
relative to pBK control. B, GRTH effect on in
vitro translation. Data are expressed as percent increases of
luciferase RNA translation induced by GRTH-GST over the GST control
(250 and 500 ng of GRTH-GST or GST). C, subcellular
localization of GRTH in mLTC by confocal microscope. Expression of
fusion protein GRTH-EGFP or EGFP alone (control) in the living cells
was examined by confocal microscope under a 40 × oil objective
len. Green fluorescence signals from GRTH-EGFP with lower amplification
(a, zoom = 2) and higher amplification (b,
zoom = 5) and from EGFP (control) with higher amplification
(c, zoom = 5) were recorded (bars = 10 µm). D, Western blot analysis. GRTH-GST and GST were
revealed by a GFP antibody. Molecular mass values are indicated on the
left.
|
|
Subcellular localization of transfected GRTH tagged with the enhanced
green fluorescence protein (GRTH-EGFP) in mLTC cells by confocal
microscopy illustrated that GRTH-EGFP was present predominantly in the
cytoplasm (Fig. 6C, a and b), whereas EGFP (control) was present throughout the nucleus, membrane, and cytoplasm (Fig. 6C, c). It could not be excluded completely
the presence of GRTH-EFGP in the nucleus since vestigial fluorescence
was observed in some transfected cells. The specificity of GRTH-EGFP
expression was assessed by Western blot using an anti-GFP monoclonal
antibody (Fig. 6D). A single band of 69 kDa which
corresponded to the GRTH-EGFP fusion protein (42 kDa, GRTH; 27 kDa,
EFGP) was observed in cells transfected with GRTH-EGFP, whereas a band
of 27 kDa was observed in EFGP-transfected cells. No bands were
detected in the negative control cells.
Purified Recombinant GRTH Displayed ATPase and RNA Helicase
Activity--
The purified recombinant GRTH-GST fusion protein (71 kDa) and recombinant GST (29 kDa) resolved as single bands on stained SDS-PAGE (Fig. 7A, left) were
utilized to assess the function of GRTH. Western blots displayed single
immunostained bands that migrated at positions that corresponded to the
stained bands (Fig. 7A, right). Whereas the purified GST
used as control showed no ATP hydrolyzing activity (Fig.
7B), the GRTH-GST displayed significant ATPase activity,
which was further stimulated 3-fold by the addition of mRNA and
poly(A) nucleotides. Addition of poly(U), total RNA, and tRNA only
increased the activity by 20-40%, whereas DNA caused a 2.5-fold
increase in activity. Omission of MgCl2 or addition of EDTA
in the reaction completely abolished the activity (data not shown).
These results demonstrated that GRTH possessed intrinsic ATPase
activity with an absolute requirement for Mg2+ and that RNA
and DNA increase the ATP hydrolyzing activity of GRTH.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 7.
Recombinant GRTH (A) for use
in GRTH ATPase (B) and helicase assays
(C). A, purified recombinant GRTH-GST
fusion protein or GST alone: left, colloidal staining of
SDS-PAGE; right, immunostaining of blot with GST antibody.
B, ATPase assays: ATP hydrolyzed by GRTH-GST or GST
(control) in the absence ( ) and presence of mRNA, poly(A),
poly(U), total RNA, tRNA, and DNA. C, helicase assays were
performed by incubation of 0.2 pmol of substrates with GRTH-GST or GST
at 37 °C for 30 min. Structure and length (bp) of RNA or DNA
substrates are indicated schematically. Short strands of RNA or DNA
were labeled by [32P]ATP. Double-stranded (ds)
substrates incubated without protein at 37 °C or heated at 100 °C
were used as negative or positive controls, respectively.
Ss, single-stranded nucleotides.
|
|
To evaluate the RNA helicase activity of GRTH, we synthesized different
duplexes of RNA/RNA, RNA/DNA, and DNA/DNA as substrates (Fig. 7C,
upper panels) and incubated with purified GRTH-GST or GST
(control). A single stretch of at least 30 bp at both 5'- and 3'-ends
of RNA or DNA was provided for the binding of GRTH-GST protein. The
double strands of RNA/RNA and RNA/DNA were unwound by GRTH-GST in a
dose-dependent manner (0.1-1.0 µg), whereas the GST
(negative control) did not show activity (Fig. 7C). Omission of ATP from the reaction abolished GRTH unwinding activity. In contrast, double-stranded DNA could not be unwound by GRTH-GST. Duplex
substrates with a 5'- or 3'-single-stranded RNA tail (provided as an
unwinding initiation site) were utilized to determine the directionality of unwinding induced by GRTH. GRTH-GST catalytically unwound both 3'- and 5'-duplexes in a dose-dependent manner
with the requirement of ATP, whereas GST controls were inactive. These results demonstrate that GRTH is an ATP-dependent
bidirectional RNA helicase.
 |
DISCUSSION |
In this study, we have cloned and characterized a novel
gonadotropin-regulated and developmentally expressed testicular RNA helicase (GRTH). This protein, which is expressed in the Leydig and
germ cells of the testis, belongs to the DEAD (Asp-Glu-Ala-Asp)-box family within the superfamily of RNA helicases (28) and contains all
the conserved domains of the family. GRTH differs from other members of
this family in having high intrinsic ATPase activity in the absence of
RNA but resembles several members (19, 21, 27), in that its ATPase
activity was remarkably enhanced in presence of mRNA, synthetic
poly(A), and DNA. Thus, GRTH not only catalyzed ATP hydrolysis to
supply energy for RNA processes but perhaps also for some other
biological processes. The DNA-enhanced ATP hydrolysis is not utilized
for the process of unwinding DNA duplexes. Bidirectional unwinding of
RNA duplexes suggested that GRTH is not only a less restricting ATPase
and but also a less restricting RNA helicase. These functional features
indicate that GRTH could be involved in a variety of biological
processes in the target tissues. It is very likely that GRTH
participates in poly(A)+-related mRNA processes
including melting the secondary structure of mRNA and initiation of translation.
GRTH is the first protein of the DEAD-box family reported to be
regulated by a hormone. The initial goal of the study was to identify
factor(s) responsible for gonadotropin down-regulation of gonadal
receptors and steroidogenic enzymes of testicular Leydig cells that
would consequently reflect the production of androgen. On the other
hand, for maintenance of the expression of relevant and/or general
cellular genes and the restoration of the cellular down-regulated
functions, some activators may be induced or enhanced during the
initial hormonal stimulus or early in the desensitization process. GRTH
was the only displayed fragment that was verified as an hCG
up-regulated gene. However, the regulation of GRTH increase by hCG did
not precede the reduction of these enzymes (2-5). This suggested that
GRTH does not play a role in the down-regulation phase of the
desensitizing process but perhaps in other gonadotropin-regulated cellular functions, including maintenance of steroidogenic enzymes and
receptors and their recovery from desensitization. In this regard, the
return of GRTH expression to control correlated with the temporal
recovery of enzymes and receptors (3-5).
We also demonstrated that the up-regulation of GRTH gene expression
results from direct and/or indirect actions at the transcriptional level of signaling molecules or metabolic products induced by hCG. The
regulation of GRTH could share aspects of the control mechanism(s)
responsible for hCG-induced down-regulation of steroidogenic enzymes
and receptors. Our cotransfection studies excluded the involvement of
GRTH as a transcriptional inhibitor responsible for hCG-induced
desensitization of receptors and steroidogenic enzymes (Fig.
6A). The similar GRTH-induced increases of reporter gene
activities driven by different promoters in the absence of mRNA
changes implied that the stimulating action of GRTH was through a
common mechanism at the post-transcriptional level. The increased in vitro translational activity induced by GRTH and the
predominant localization of GRTH-GFP in the cytoplasm of transfected
cells (Fig. 6, B and C) support its involvement
in the translational process. However, its participation in other
biological processes cannot be excluded, since weak nuclear
localization was observed, and both RNA and DNA can stimulate ATPase
activity of GRTH. Thus, it is conceivable that the up-regulation of the
GRTH gene product induced by the hormonal stimuli may contribute to the
translatability of hormone receptors and steroidogenic enzymes and
other proteins.
GRTH is specifically expressed in male but not in female gonadal
tissue. In addition to its expression in the Leydig cells of the
interstitial compartment of the testis, GRTH is also highly expressed
in meiotic and round haploid germinal cells (Fig. 3). Differentiation
in germ cells requires enhanced activation of transcription and
translation of specific genes in which GRTH may play important roles.
Interestingly, some members of the RNA helicase family were expressed
differentially during development or restrictively distributed in germ
cells (24-26, 29), and it has been suggested that these proteins may
actively participate in sexual development (25) and in the process of
oogenesis (24, 29) and spermatogenesis (26). The structure and function
of GRTH links this new helicase with other members of the RNA helicase family, including eIF4A (22, 30), Ded1p (31), and PL10 proteins (26).
The male gonad-specific expression of GRTH and the striking increase of
its mRNA in pubertal and post-pubertal rodents suggest that GRTH is
functionally related to gonadal maturation and spermatogenesis. The
developmental increase in GRTH in the pubertal rodent testis occurs at
the same time as gonadotropin-induced androgen responses appear in the
Leydig cell (32), and when the differentiation of germ cells that
ultimately leads to the development of haploid spermatids begins to
occur (33). It is reasonable to propose that the steroid hormone
produced in the gonadotropin-stimulated testis could not only exert
intracrine or autocrine actions on GRTH gene expression in the Leydig
cell but may also influence GRTH gene transcription within the
seminiferous tubule. The notably high expression of the helicase in
pachytene spermatocytes indicates that GRTH may be one of the genes
involved in the meiotic process that has a crucial role in
spermatogenesis (34).
The specific expression of GRTH in the testis, but not in ovary,
implies that its gene is either suppressed by female-specific or
induced by male-specific gonadal factor(s). Since estrogen is produced
in both male and female gonads, it is unlikely to be involved in the
induction of GRTH gene expression. Consistent with this, estradiol did
not affect GRTH mRNA in cultured rat Leydig cells. In contrast, the
non-metabolizable androgen, dihydrotestosterone, increased the
expression of GRTH mRNA in Leydig cells. The stimulation effects of
hCG in vivo on the GRTH gene expression were also observed in vitro, and cAMP, the second messenger of hCG action, had
comparable effects. However, no stimulation was observed after
inhibition of steroid biosynthetic enzymes, which abolished hCG- and
cAMP-stimulated increases of testosterone in Leydig cells. The absence
of a rapid change in basal GRTH mRNA levels during androgen
suppression in vitro is not unexpected, since incubations
could only be conducted with short term primary cultures and the GRTH
mRNA is long-lived (Fig. 4C). Androgen induced by
gonadotropin could act through its cognate receptors in the Leydig cell
to increase GRTH gene expression. It could also exert actions in the
germinal cells of the seminiferous epithelium through androgen
receptors present in Sertoli cells, since germinal cells do not possess
androgen receptors (35). Although androgens are not present in the
pituitary, hypothalamus, and brain, where low GRTH mRNA levels are
found, androgen receptors are present in these tissues. It is
conceivable that androgen from the circulation may induce GRTH
expression at these sites. Major developmental changes in GRTH mRNA
were observed during puberty when predominant expression of GRTH
mRNA was observed in the Leydig cell and germinal epithelium. Our
findings suggest that this novel testicular helicase could serve to
maintain testicular functions related to steroidogenesis and spermatogenesis.
 |
ACKNOWLEDGEMENT |
We are grateful to Dr. Kenneth S. K. Tung
(Department of Pathology, University of Virginia Medical School,
Charlottesville, VA) for valuable advice on histological interpretation.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF142629, AF142630, AF155140.
To whom correspondence should be addressed: Bldg. 49, Rm. 6A36, 49 Convent Dr. MSC4510, National Institutes of Health, Bethesda, MD
20892-4510. Tel.: 301-496-2021: Fax: 301-480-8010: E-mail: dufau@helix.nih.gov.
 |
ABBREVIATIONS |
The abbreviations used are:
LH, luteinizing
hormone;
hCG, human chorionic gonadotropin;
GRTH, gonadotropin-regulated testicular RNA helicase;
PCR, polymerase chain
reaction;
FISH, fluorescence in situ hybridization;
bp, base
pair;
GST, glutathione S-transferase;
PAGE, polyacrylamide
gel electrophoresis;
BSA, bovine serum albumin;
kb, kilobase pairs;
nt, nucleotide EGFP, enhanced green fluorescence protein;
GFP, green
fluorescence protein.
 |
REFERENCES |
| 1.
|
Dufau, M. L.
(1988)
Annu. Rev. Physiol.
50,
483-508[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Dufau, M. L.,
Cigorraga, S. B.,
Baukal, A. J.,
Bator, J. M.,
Sorrell, S. H.,
Neubauer, J. F.,
and Catt, K. J.
(1979)
J. Steroid Biochem.
11,
193-199[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Tang, P. Z.,
Tsai-Morris, C. H.,
and Dufau, M. L.
(1998)
Endocrinology
139,
4496-4505[Abstract/Free Full Text]
|
| 4.
|
Tsai-Morris, C. H.,
Khanum, A.,
Tang, P.-Z.,
and Dufau, M. L.
(1999)
Endocrinology
140,
3534-3542[Abstract/Free Full Text]
|
| 5.
|
Nishihara, M.,
Winters, C. A.,
Buzko, E.,
Waterman, M. R.,
and Dufau, M. L.
(1988)
Biochem. Biophys. Res. Commun.
154,
151-158[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Dufau, M. L.,
and Catt, K. J.
(1978)
Vitam. Horm.
36,
461-592[Medline]
[Order article via Infotrieve]
|
| 7.
|
Nozu, K.,
Dehejia, A.,
Zawistowich, L.,
Catt, K. J.,
and Dufau, M. L.
(1981)
J. Biol. Chem.
256,
12875-12882[Free Full Text]
|
| 8.
|
Nozu, K.,
Matsuura, S.,
Catt, K. J.,
and Dufau, M. L.
(1981)
J. Biol. Chem.
256,
10012-10017[Free Full Text]
|
| 9.
|
Aquilano, D. R.,
and Dufau, M. L.
(1984)
Endocrinology
114,
499-510[Abstract/Free Full Text]
|
| 10.
|
Cigorraga, S. B.,
Dufau, M. L.,
and Catt, K. J.
(1978)
J. Biol. Chem.
253,
4297-4304[Free Full Text]
|
| 11.
|
Aquilano, D. R.,
Tsai-Morris, C. H.,
Hattori, M. A.,
and Dufau, M. L.
(1985)
Endocrinology
116,
1745-1754[Abstract/Free Full Text]
|
| 12.
|
Khanum, A.,
Buczko, E.,
and Dufau, M. L.
(1997)
Endocrinology
138,
1612-1620[Abstract/Free Full Text]
|
| 13.
|
Liang, P.,
and Pardee, A. B.
(1992)
Science
257,
967-971[Abstract/Free Full Text]
|
| 14.
|
Gilman, M.
(1987)
in
Current Protocols in Molecular Biology
(Ausubel, F. M.
, Brent, R.
, Kingston, R. E.
, Moore, D. D.
, Seidman, J. G.
, Smith, J. A.
, and Struhl, K., eds)
, pp. 4.7.1-4.7.8, Greene Publishing Associates and Wiley-Interscience, New York
|
| 15.
|
Heng, H. H.,
Squire, J.,
and Tsui, L. C.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
9509-9513[Abstract/Free Full Text]
|
| 16.
|
Greenberg, M. E.,
and Bender, T. P.
(1990)
in
Current Protocols in Molecular Biology
(Ausubel, F. M.
, Brent, R.
, Kingston, R. E.
, Moore, D. D.
, Seidman, J. G.
, Smith, J. A.
, and Struhl, K., eds)
, pp. 4.10.1-4.10.9, Greene Publishing Associates and Wiley-Interscience, New York
|
| 17.
|
Fox, C. H.,
and Cottler-Fox, M.
(1993)
in
Current Protocols in Immunology
(Coligan, J.
, and Kruisbeek, A., eds)
, pp. 2.8.1-2.8.21, John Wiley & Sons, Inc., New York
|
| 18.
|
Merrick, W. C.,
and Sonenberg, N.
(1997)
Methods
11,
333-342[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Pause, A.,
and Sonenberg, N.
(1992)
EMBO J.
11,
2643-2654[Medline]
[Order article via Infotrieve]
|
| 20.
|
Gee, S. L.,
and Conboy, J. G.
(1994)
Gene (Amst.)
140,
171-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Tseng, S. S.,
Weaver, P. L.,
Liu, Y.,
Hitomi, M.,
Tartakoff, A. M.,
and Chang, T. H.
(1998)
EMBO J.
17,
2651-2662[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Jaramillo, M.,
Dever, T. E.,
Merrick, W. C.,
and Sonenberg, N.
(1991)
Mol. Cell. Biol.
11,
5992-5997[Abstract/Free Full Text]
|
| 23.
|
Lu, D.,
and Yunis, J. J.
(1992)
Nucleic Acids Res.
20,
1967-1972[Abstract/Free Full Text]
|
| 24.
|
de Valoir, T.,
Tucker, M. A.,
Belikoff, E. J.,
Camp, L. A.,
Bolduc, C.,
and Beckingham, K.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
2113-2117[Abstract/Free Full Text]
|
| 25.
|
Maekawa, H.,
Nakagawa, T.,
Uno, Y.,
Kitamura, K.,
and Shimoda, C.
(1994)
Mol. Gen. Genet.
244,
456-464[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Leroy, P.,
Alzari, P.,
Sassoon, D.,
Wolgemuth, D.,
and Fellous, M.
(1989)
Cell
57,
549-559[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Hirling, H.,
Scheffner, M.,
Restle, T.,
and Stahl, H.
(1989)
Nature
339,
562-564[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Schmid, S. R.,
and Linder, P.
(1992)
Mol. Microbiol.
6,
283-291[Medline]
[Order article via Infotrieve]
|
| 29.
|
Gururajan, R.,
Perry, O. K. H.,
Melton, D. A.,
and Weeks, D. L
(1991)
Nature
349,
717-719[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Rozen, F.,
Edery, I.,
Meerovitch, K.,
Dever, T. E.,
Merrick, W. C.,
and Sonenberg, N.
(1990)
Mol. Cell. Biol.
10,
1134-1144[Abstract/Free Full Text]
|
| 31.
|
Chuang, R. Y.,
Weaver, P. L.,
Liu, Z.,
and Chang, T. H.
(1997)
Science
275,
1468-1471[Abstract/Free Full Text]
|
| 32.
|
Huhtaniemi, I. T.,
Nozu, K.,
Warren, D. W.,
Dufau, M. L.,
and Catt, K. J.
(1982)
Endocrinology
111,
1711-1720[Abstract/Free Full Text]
|
| 33.
|
Clermont, Y.,
and Perey, B.
(1957)
Am. J. Anat.
100,
241-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Edelmann, W.,
Cohen, P. E.,
Kane, M.,
Lau, K.,
Morrow, B.,
Bennett, S.,
Umar, A.,
Kunkel, T.,
Cattoretti, G.,
Chaganti, R.,
Pollard, J. W.,
Kolodner, R. D.,
and Kucherlapati, R.
(1996)
Cell
85,
1125-1134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Bremner, W. J.,
Millar, M. R.,
Sharpe, R. M.,
and Saunders, P. T.
(1994)
Endocrinology
135,
1227-1234[Abstract]
|
| 36.
|
Tsai-Morris, C. H.,
Geng, Y.,
Xie, X. Z.,
Buczko, E.,
and Dufau, M. L.
(1994)
J. Biol. Chem.
269,
15868-15875[Abstract/Free Full Text]
|
| 37.
|
Tsai-Morris, C. H.,
Geng, Y.,
Buczko, E.,
and Dufau, M. L.
(1998)
J. Clin. Endocrinol. & Metab.
83,
288-291[Abstract/Free Full Text]
|
| 38.
|
Hu, Z.,
Zhuang, L.,
Guan, X.,
Meng, J.,
and Dufau, M. L.
(1997)
J. Biol. Chem.
272,
14263-14271[Abstract/Free Full Text]
|
| 39.
|
Dufau, M. L.,
Miyagawa, Y.,
Takada, S.,
Khanum, A.,
Miyagawa, H.,
and Buczko, E.
(1997)
Steroids
62,
128-132[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C.-H. Tsai-Morris, E. Koh, and M. L. Dufau
Differences in gonadotropin-regulated testicular helicase (GRTH/DDX25) single nucleotide polymorphism between Japanese and Chinese populations
Hum. Reprod.,
November 1, 2008;
23(11):
2611 - 2613.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Gutti, C.-H. Tsai-Morris, and M. L. Dufau
Gonadotropin-regulated Testicular Helicase (DDX25), an Essential Regulator of Spermatogenesis, Prevents Testicular Germ Cell Apoptosis
J. Biol. Chem.,
June 20, 2008;
283(25):
17055 - 17064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Tsai-Morris, E. Koh, Y. Sheng, Y. Maeda, R. Gutti, M. Namiki, and M. L. Dufau
Polymorphism of the GRTH/DDX25 gene in normal and infertile Japanese men: a missense mutation associated with loss of GRTH phosphorylation
Mol. Hum. Reprod.,
December 1, 2007;
13(12):
887 - 892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sheng, C.-H. Tsai-Morris, R. Gutti, Y. Maeda, and M. L. Dufau
Gonadotropin-regulated Testicular RNA Helicase (GRTH/Ddx25) Is a Transport Protein Involved in Gene-specific mRNA Export and Protein Translation during Spermatogenesis
J. Biol. Chem.,
November 17, 2006;
281(46):
35048 - 35056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Linder
Dead-box proteins: a family affair--active and passive players in RNP-remodeling
Nucleic Acids Res.,
September 10, 2006;
34(15):
4168 - 4180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. A, S. Zhang, Y. Yang, Y. Ma, L. Lin, and W. Zhang
Single nucleotide polymorphisms of the gonadotrophin-regulated testicular helicase (GRTH) gene may be associated with the human spermatogenesis impairment
Hum. Reprod.,
March 1, 2006;
21(3):
755 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-H. Tsai-Morris, Y. Sheng, E. Lee, K.-J. Lei, and M. L. Dufau
Gonadotropin-regulated testicular RNA helicase (GRTH/Ddx25) is essential for spermatid development and completion of spermatogenesis
PNAS,
April 27, 2004;
101(17):
6373 - 6378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sheng, C.-H. Tsai-Morris, and M. L. Dufau
Cell-specific and Hormone-regulated Expression of Gonadotropin-regulated Testicular RNA Helicase Gene (GRTH/Ddx25) Resulting from Alternative Utilization of Translation Initiation Codons in the Rat Testis
J. Biol. Chem.,
July 18, 2003;
278(30):
27796 - 27803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Anway, Y. Li, N. Ravindranath, M. Dym, and M. D. Griswold
Expression of Testicular Germ Cell Genes Identified by Differential Display Analysis
J Androl,
March 1, 2003;
24(2):
173 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Yan, J.-F. Mouillet, Q. Ou, and Y. Sadovsky
A Novel Domain within the DEAD-Box Protein DP103 Is Essential for Transcriptional Repression and Helicase Activity
Mol. Cell. Biol.,
January 1, 2003;
23(1):
414 - 423.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P.-Z. Tang, C.-H. Tsai-Morris, and M. L. Dufau
Cloning and characterization of a hormonally regulated rat long chain acyl-CoA synthetase
PNAS,
May 24, 2001;
(2001)
121046998.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Z. Tang, C.-H. Tsai-Morris, and M. L. Dufau
Cloning and characterization of a hormonally regulated rat long chain acyl-CoA synthetase
PNAS,
June 5, 2001;
98(12):
6581 - 6586.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|